Department of Engineering Science, Institute of Biomedical Engineering, University of Oxford, Old Road Campus Research Building, Off Roosevelt Drive, Oxford OX3 7DQ, UK.
J R Soc Interface. 2010 Aug 6;7 Suppl 4(Suppl 4):S483-500. doi: 10.1098/rsif.2010.0114.focus. Epub 2010 Jun 2.
The feasibility of preparing microparticles with high insulin loading suitable for needle-free ballistic drug delivery by spray-freeze-drying (SFD) was examined in this study. The aim was to manufacture dense, robust particles with a diameter of around 50 microm, a narrow size distribution and a high content of insulin. Atomization using ultrasound atomizers showed improved handling of small liquid quantities as well as narrower droplet size distributions over conventional two-fluid nozzle atomization. Insulin nanoparticles were produced by SFD from solutions with a low solid content (<10 mg ml(-1)) and subsequent ultra-turrax homogenization. To prepare particles for needle-free ballistic injection, the insulin nanoparticles were suspended in matrix formulations with a high excipient content (>300 mg ml(-1)) consisting of trehalose, mannitol, dextran (10 kDa) and dextran (150 kDa) (abbreviated to TMDD) in order to maximize particle robustness and density after SFD. With the increase in insulin content, the viscosity of the nanosuspensions increased. Liquid atomization was possible up to a maximum of 250 mg of nano-insulin suspended in a 1.0 g matrix. However, if a narrow size distribution with a good correlation between theoretical and measurable insulin content was desired, no more than 150 mg nano-insulin could be suspended per gram of matrix formulation. Particles were examined by laser light diffraction, scanning electron microscopy and tap density testing. Insulin stability was assessed using size exclusion chromatography (SEC), reverse phase chromatography and Fourier transform infrared (FTIR) spectroscopy. Densification of the particles could be achieved during primary drying if the product temperature (T(prod)) exceeded the glass transition temperature of the freeze concentrate (T(g)') of -29.4 degrees C for TMDD (3331) formulations. Particles showed a collapsed and wrinkled morphology owing to viscous flow of the freeze concentrate. With increasing insulin loading, the d (v, 0.5) of the SFD powders increased and particle size distributions got wider. Insulin showed a good stability during the particle formation process with a maximum decrease in insulin monomer of only 0.123 per cent after SFD. In accordance with the SEC data, FTIR analysis showed only a small increase in the intermolecular beta-sheet of 0.4 per cent after SFD. The good physical stability of the polydisperse particles made them suitable for ballistic injection into tissue-mimicking agar hydrogels, showing a mean penetration depth of 251.3 +/- 114.7 microm.
本研究旨在考察通过喷雾冷冻干燥(SFD)制备适用于无针弹道药物输送的高胰岛素载量微球的可行性。目的是制造直径约为 50 微米、粒径分布窄、胰岛素含量高的致密、坚固的颗粒。与传统的双流喷嘴雾化相比,超声雾化器雾化可改善小液量的处理能力,并使液滴粒径分布更窄。通过 SFD 从低固体含量(<10mgml(-1))的溶液中制备胰岛素纳米粒,并随后进行超高速匀浆处理。为了制备适用于无针弹道注射的颗粒,将胰岛素纳米粒混悬于含有高赋形剂含量(>300mgml(-1))的基质配方中,该配方由海藻糖、甘露醇、葡聚糖(10kDa)和葡聚糖(150kDa)组成(简称 TMDD),以在 SFD 后最大程度地提高颗粒的坚固性和密度。随着胰岛素含量的增加,纳米混悬液的粘度增加。在 1.0g 基质中最多可悬浮 250mg 的纳米胰岛素进行液体雾化。然而,如果希望粒径分布较窄且理论和可测量的胰岛素含量之间具有良好的相关性,则每克基质配方中最多只能悬浮 150mg 的纳米胰岛素。通过激光光散射、扫描电子显微镜和振实密度测试对颗粒进行了检查。使用尺寸排阻色谱(SEC)、反相色谱和傅里叶变换红外(FTIR)光谱法评估胰岛素的稳定性。如果产品温度(T(prod))超过 TMDD(3331)配方的冷冻浓缩物的玻璃化转变温度(T(g)')-29.4 摄氏度,则在初级干燥期间可以实现颗粒的致密化。由于冷冻浓缩物的粘性流动,颗粒呈现出塌陷和起皱的形态。随着胰岛素载药量的增加,SFD 粉末的 d(v,0.5)增加,粒径分布变宽。胰岛素在颗粒形成过程中具有良好的稳定性,SFD 后胰岛素单体的最大减少量仅为 0.123%。根据 SEC 数据,FTIR 分析表明 SFD 后仅增加了 0.4%的分子间β-折叠。多分散颗粒的良好物理稳定性使其适用于弹道注射到组织模拟琼脂水凝胶中,平均穿透深度为 251.3±114.7μm。